Please wait whilst we download the studies recruiting in and from your area of residence ...





Student Accommodation, Accommodation, Cheap Accommodation, Rooms To Let, Share Accommodation, Flat Lettings, Flats To Let, Hotel Accommodation, Houses To Let, Letting Agencies, Letting Agents, Properties To Let, Property Rentals, Rental Accommodation, Lettings, Private Lettings, Property Lettings, Residential Lettings in West Virginia

8 studies recruit in and from this area

NEW TO BIOTRAX EMAIL A YOU TUBE TO FRIENDS AT THE TOP OF ALL STUDY LISTINGS

ALSO EMAIL PARTICULAR STUDIES COMPLETE WITH YOU TUBE FOR UP TO 3 FRIENDS.

Study 1277 :ARE YOU SUFFERING FROM DRUG-INDUCED TARDIVE DYSKINESIA - Houston only
Texas



Type of StudyInterventional
Aim of StudyHave you ever taken an anti-psychotic medication or Reglan and developed uncontrolled muscle movements? You may qualify for a research study at Baylor College of Medicine.
Inclusion CriteriaYou must be between 18 and 75 years of age and have uncontrolled muscle movements for at least 3 months.
Exclusion CriteriaShould not less than 18 years
AreaHouston
TX
DurationNot Given
ReimbursementWill be compensate for time and travel
Free GiftNot Given
Other InfoStudy Id :1745
Noteswe need participants from Houston only

Study 481 :Need healthy participants in New York for Kappa Opioid Receptor Imaging in PTSD
New York



Type of StudyWe are looking for healthy participants who are medically healthy and NOT currently taking medications. Eligible participants will receive compensation for their time.

Aim of StudyNeed healthy participants in New York for Kappa Opioid Receptor Imaging in PTSD

Therapeutic Area: Psychiatry/Psychology

Medical Condition(s): Healthy control subjects
Inclusion CriteriaWe are looking for subjects who:
• Are medically healthy
• Have not been treated for a psychological condition in the past or current
• Are not taking any medications
• Are 18-55 years of age
Exclusion CriteriaThe following subjects will be excluded from the study:
• Pregnant or nursing
• Subjects with an unstable medical condition or illness
• Subjects currently taking recreational drugs or abusing alcohol
AreaNew York
Durationn/a
ReimbursementEligible participants will receive compensation for their time.
NotesCenter Contact Information

Center Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU
Contact Name: Jordan Seidel
Title: Research Coordinator


Study 480 :Volunteers Need in at NYU - Kappa Opioid Receptor Imaging in Anorexia
New York



Type of StudyWe are looking for healthy participants who are medically healthy and NOT currently taking medications. Eligible participants will receive compensation for their time.
Aim of StudyUrgently Volunteers Need in at NYU - Kappa Opioid Receptor Imaging in Anorexia

Therapeutic Area: Psychiatry/Psychology

Medical Condition(s): Healthy control subjects
Inclusion CriteriaWe are looking for subjects who:
• Are medically healthy
• Have not been treated for a psychological condition in the past or current
• Are not taking any medications
• Are 18-55 years of age

Exclusion CriteriaThe following subjects will be excluded from the study:
• Pregnant or nursing
• Subjects with an unstable medical condition or illness
• Subjects currently taking recreational drugs or abusing alcohol
AreaNew York
Durationn/a
ReimbursementEligible participants will receive compensation for their time.
NotesCenter Contact Information

Center Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU
Contact Name: Jordan Seidel
Title: Research Coordinator


Study 1550 :US - A NEW FREE LETTINGS & ACCOMMODATION SERVICE IN THE US
Alabama



Type of StudyUS - LETTINGS & ACCOMMODATION INFO POST


US, Student Accommodation, Accommodation, Cheap Accommodation, Rooms To Let, Share Accommodation, Flat Lettings, Flats To Let, Hotel Accommodation, Houses To Let, Letting Agencies, Letting Agents, Properties To Let, Property Rentals, Rental Accommodation, Lettings, Private Lettings, Property Lettings, Residential Lettings.
Aim of StudyA NEW FREE LETTINGS & ACCOMMODATION SERVICE IN THE US
Area US Wide
Including, Alabama, AL, Alaska, AS, Arizona, AZ, Arkansas, AR, Califronia, CA, Colorado, CO. Connecticut, CT, Delaware. DE, District of Columbia, DC, Florida, FL, Georgia, GA, Hawaii, HI, Idaho, ID, Illinois, IL, Indiana, IN, Iowa, IA, Kansas, KS, Ketucky, KY, Louisiana,LA, Maine, ME, Maryland, MD, Massachusetts, MA, Michigan, MI, Minnisota, MN, Mississippi, MS, Missouri, MO, Montana, MT, Nebraska, NE, Nevada, NV, New Hampshire, NH, New Jersey, NJ, New Mexico, NM, New York, NY, North Carolina, NC, North Dakota, ND, Ohio, OH, Oklahoma, OK. Oregon, OR, Pennsylvania, PA, Puerto Rico, PR, Rhode, Island, RI, South Carolina, SC, South Dakota, SD, Tennesse, TN, Texas, TX, Utah, UT, Vermont, VT, Virginia, VA, Washington, WA, West Virginia WV, Wisconsin, WI, Wyoming, WY

Study 560 :Functional Brain Imaging in PTSD
New York



Type of StudyPsychiatry/Psychology

We are looking for participants suffering from posttraumatic stress disorder (PTSD) who are NOT currently taking medication. Eligible participants will receive compensation for their time. This study does NOT provide treatment.
Aim of StudyPosttraumatic Stress Disorder
Inclusion Criteria We are looking for subjects who:
• Have experienced a traumatic event (i.e., serious accident, natural disaster, violent crime, sexual assault or rape, being in a military war zone or combat)
• Are not taking any psychiatric medications
• Are 18-55 years of age
Exclusion Criteria The following subjects will be excluded from the study:
• Pregnant or nursing
• Subjects with an unstable medical condition or illness
• Subjects currently taking recreational drugs or abusing alcohol
AreaNew York
Durationnot given
Reimbursementplease contact us so we can discuss further
Other Info Contact Name: Jordan Seidel
Title: Research Coordinator
Address: New York University School of Medicine, One Park Avenue, 8th Floor, Room 8-227, New York, NY 10016, United States

Study 1157 :Kappa Opiate Receptor Imaging in PTSD
New York



Type of StudyTherapeutic Area: Psychiatry/Psychology

Medical Condition(s): Posttraumatic Stress Disorder
Aim of StudyWe are looking for participants suffering from posttraumatic stress disorder (PTSD) who are NOT currently taking medication. Eligible participants will receive compensation for their time. This study does NOT provide treatment.
Inclusion CriteriaWe are looking for subjects who:
• Have experienced a traumatic event (i.e., serious accident, natural disaster, violent crime, sexual assault or rape, being in a military war zone or combat)
• Are not taking any psychiatric medications
• Are 18-55 years of age
Exclusion CriteriaThe following subjects will be excluded from the study:
• Pregnant or nursing
• Subjects with an unstable medical condition or illness (besides depression)
• Subjects currently taking recreational drugs or abusing alcohol
AreaNew York, NYC
Durationnot given
Reimbursementplease contact us to discuss further.
Other InfoCenter Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU
Contact Name:Jordan Seidel
Title:Research Coordinator
Address: New York University School of Medicine, One Park Avenue, 8th Floor, Room 8-227, New York, NY 10016, United States

Study 490 :Need participants suffering from depression in New York - KOR Depression
New York



Type of StudyWe are looking for participants suffering from depression who are NOT currently taking medication. Eligible participants will receive compensation for their time.
Aim of StudyUrgently need participants suffering from depression in New York - KOR Depression

Therapeutic Area: Psychiatry/Psychology

Medical Condition(s): Depression
Inclusion CriteriaWe are looking for subjects who:
• Are experiencing symptoms of depression and anxiety
• Are not taking any psychiatric medications
• Are 18-55 years of age

Exclusion CriteriaThe following subjects will be excluded from the study:
• Pregnant or nursing
• Subjects with an unstable medical condition or illness (besides depression)
• Subjects currently taking recreational drugs or abusing alcohol

AreaNew York
DurationN/a
ReimbursementEligible participants will receive compensation for their time.
Other InfoStudy Number: S14-00643
NotesCenter Contact Information

Center Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU
Contact Name: Jordan Seidel
Title: Research Coordinator

Study 1278 :Get $1,575 - STUDY TO ASSESS EFFECTS OF PF-04457845 ON BOLD FUNCTIONAL MRI IN SUBJECTS WITH PTSD
New York



Type of StudyBOLD FUNCTIONAL MRI IN SUBJECTS WITH PTSD
Aim of StudyPF-04457845 is a fatty acid amide hydrolase (FAAH) inhibitor. FAAH is responsible for hydrolyzing the fatty acid amide, anandamide (AEA). Stress induces increases in FAAH activity which result in decreased brain levels of the endocannabinoid (eCB), AEA and reduced signaling via cannabinoid type 1 receptors (CB1). Deficits in eCB signaling may play a key role in the etiology of PTSD and may mediate important components of the PTSD phenotype.

Our hypothesis is that the increase in brain AEA levels achieved by inhibition of FAAH will restore signaling through CB1 in a regionally specific manner and thus alleviate the effects of stress.
Inclusion Criteria1. Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.

2. Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.

3. Male and female subjects of childbearing potential and at risk for pregnancy must agree to use of a highly effective method of contraception throughout the study and for at least the 28 days after the last dose of assigned treatment.

4. Female subjects of non-childbearing potential must meet at least one of the following criteria:
a. Have undergone a documented hysterectomy and/or bilateral oophorectomy.
b. Have medically confirmed ovarian failure.
c. Achieved postmenopausal status, defined as follows: cessation of regular menses for at least 12 consecutive months with no alternative pathological or physiological cause; status may be confirmed by having a serum follicle-stimulating hormone (FSH) level within the laboratory’s reference range for postmenopausal women.

All other female subjects (including females with tubal ligations and females that do
NOT have a documented hysterectomy, bilateral oophorectomy and/or ovarian failure) will be considered to be of childbearing potential.

5. Healthy male and/or female subjects between the ages of 18 and 60 years, inclusive.
Healthy is defined as no clinically relevant abnormalities identified by a detailed medical history, full physical examination, including blood pressure and pulse rate measurement, 12-lead ECG and clinical laboratory tests.

6. Body Mass Index (BMI) of 17.5 to 32 kg/m2; and a total body weight _50 kg (110 lbs).

7. Subjects who are right handed.

8. Subjects who can read, speak, and comprehend English.

9. Subjects must be outpatients with a primary diagnosis of PTSD (DSM-V criteria 309.81). Symptom severity must be such that subjects have a Clinician-administered CAPS (_35) and CGI-S score (_3) at both Screening and Day 1 (baseline) visits to qualify for clinical trial entry.

PTSD must be the primary psychiatric disorder present (confirmed by Structured Clinical Interview for DSM IV research version patient edition (SCID-RV/P) and the condition that motivated the subject to seek treatment.

Subjects with concurrent diagnoses of MDD, which is no more than moderate in severity, dysthymic disorder, generalized anxiety disorder, specific phobia, or social phobia, are eligible, if PTSD is the primary diagnosis and the subject is not currently requiring psychopharmacological intervention for these conditions.
Exclusion CriteriaWho do not match above requirments
AreaNew York
Duration28 days
ReimbursementSubjects will receive $1,575 for being in this study.
Other InfoStudy Coordinator: Jordan Seidel, MA; Jordan.Seidel@nyumc.org; 646-754-4829